Stephen Macevicz has joined Aclara Biosciences as vice president of intellectual property, according to SEC filings. Macevicz, 53, was previously vice president of intellectual property at GeneProt, which he joined last year. Prior to that, he was VP of IP for Lynx Therapeutics, and before that was senior patent attorney and chief patent counsel at Applied Biosystems. He started at Aclara in March 2002.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.